Companies: 10,795·Total market cap: $144.5T
Appili Therapeutics Inc.

Appili Therapeutics Inc.

APLI.TOTSXHealthcare● Active
$0.02
+$0.00(+0.00%)
Market Cap$1925490
P/E Ratio
52W High$0.04
52W Low$0.01
Overview

Appili Therapeutics Inc.(APLI.TO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · APLI.TO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-032021-03
Revenue
Revenue$0.10M$0.83M$0.33M$1.39M$0.00M
Cost of Revenue$0.00M$0.00M$0.01M$0.00M$0.01M
Gross Profit$0.10M$0.83M$0.33M$1.39M($0.01M)
Gross Margin %(computed)100.00%100.00%98.12%100.00%
Operating Expenses
R&D Expenses$7.33M$5.62M$3.81M$21.46M$11.49M
G&A Expenses$2.85M$3.05M$4.44M$4.61M$4.79M
Total Operating Expenses$0.29M$2.92M$8.11M$24.95M$16.28M
Operating Income($0.19M)($2.16M)($7.91M)($24.68M)($16.30M)
Operating Margin %(computed)-190.00%-261.39%
Interest Income$0.00M$0.02M$0.03M$0.03M$0.12M
Interest Expense$3.50M$1.63M$1.10M$1.55M$0.07M
Income Before Tax($2.61M)($3.71M)($9.21M)($25.08M)($14.95M)
Income Tax Expense$0.02M$0.07M$0.04M$0.04M($0.63M)
Net Income($2.62M)($3.78M)($9.24M)($25.12M)($14.33M)
Net Margin %(computed)-456.96%
Per Share & EBITDA
EPS (Basic)$-0.02$-0.03$-0.08$-0.38$-0.24
Wtd Avg Shares121.27M121.27M113.73M66.73M59.18M
EBITDA$0.36M($2.07M)($8.10M)($23.51M)($14.87M)
EBITDA Margin %(computed)358.98%-249.78%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解Appili Therapeutics Inc.

关于Appili Therapeutics Inc.(APLI.TO)损益表

Appili Therapeutics Inc.(APLI.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,APLI.TO实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.00B)(净利率-2613.12%)。

常见问题

APLI.TO · 4 问

Appili Therapeutics Inc.(APLI.TO)2025财年营收为$0.00B,同比down87.9%。

APLI.TO revenueAPLI.TO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09